FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2004991008> ?p ?o ?g. }

• W2004991008 endingPage "684" @default.
• W2004991008 startingPage "677" @default.
• W2004991008 abstract "Seasonal influenza vaccination offers one of the best population-level protections against influenza-like illness (ILI). For most people, a single dose prior to the flu season offers adequate immunogenicity. HIV+ patients, however, tend to exhibit a shorter period of clinical protection, and therefore may not retain immunogenicity for the entire season. Building on the work of Nosyk et al. (2011) that determined a single dose is the optimal dosing strategy for HIV+ patients, we investigate the optimal time to administer this vaccination. Using data from the “single dose” treatment arm of an RCT conducted at 12 CIHR Canadian HIV Trials Network sites we estimated semimonthly clinical seroprotection levels for a cohort (N = 93) based on HAI titer levels. These estimates were combined with CDC attack rate data for the three main strains of seasonal influenza to estimate instances of ILI over different vaccination timing strategies. Using bootstrap resampling of the cohort, nine years of CDC data, and parameter distributions, we developed a Markov cohort model that included probabilistic sensitivity analysis. Cost, quality adjusted life-years (QALYs), and net monetary benefits are presented for each timing strategy. The beginning of December is the optimal time for HIV+ patients to receive the seasonal influenza vaccine. Assuming a willingness-to-pay threshold of $50,000, the net monetary benefit associated with a Dec 1 vaccination date is $19,501.49 and the annual QALY was 0.833744. Our results support a policy of administering the seasonal influenza vaccination for this population in the middle of November or beginning of December, assuming nothing is know about the upcoming flu season. But because the difference in between this strategy and the CDC guideline is small—12 deaths averted per year and a savings of $60 million across the HIV+ population in the US—more research is needed concerning strategies for subpopulations." @default.
• W2004991008 created "2016-06-24" @default.
• W2004991008 creator A5002438508 @default.
• W2004991008 creator A5009499168 @default.
• W2004991008 creator A5029936113 @default.
• W2004991008 creator A5052496992 @default.
• W2004991008 creator A5080964631 @default.
• W2004991008 creator A5084650313 @default.
• W2004991008 date "2014-02-01" @default.
• W2004991008 modified "2023-09-27" @default.
• W2004991008 title "Optimal timing of influenza vaccination in patients with human immunodeficiency virus: A Markov cohort model based on serial study participant hemoagglutination inhibition titers" @default.
• W2004991008 cites W121013250 @default.
• W2004991008 cites W1568534433 @default.
• W2004991008 cites W1886211768 @default.
• W2004991008 cites W1889532030 @default.
• W2004991008 cites W1964178035 @default.
• W2004991008 cites W1978959016 @default.
• W2004991008 cites W1995945562 @default.
• W2004991008 cites W2001187841 @default.
• W2004991008 cites W2002459404 @default.
• W2004991008 cites W2013108239 @default.
• W2004991008 cites W2019031126 @default.
• W2004991008 cites W2023665088 @default.
• W2004991008 cites W2036520460 @default.
• W2004991008 cites W2045130367 @default.
• W2004991008 cites W2059629703 @default.
• W2004991008 cites W2059684539 @default.
• W2004991008 cites W2067100208 @default.
• W2004991008 cites W2070157976 @default.
• W2004991008 cites W2070208649 @default.
• W2004991008 cites W2079810016 @default.
• W2004991008 cites W2083080765 @default.
• W2004991008 cites W2095044543 @default.
• W2004991008 cites W2095172817 @default.
• W2004991008 cites W2116465729 @default.
• W2004991008 cites W2119019497 @default.
• W2004991008 cites W2138714943 @default.
• W2004991008 cites W2148853190 @default.
• W2004991008 cites W2157547565 @default.
• W2004991008 cites W2159850238 @default.
• W2004991008 cites W2171028594 @default.
• W2004991008 cites W2171996923 @default.
• W2004991008 cites W2291103013 @default.
• W2004991008 cites W26131945 @default.
• W2004991008 cites W85469694 @default.
• W2004991008 doi "https://doi.org/10.1016/j.vaccine.2013.11.103" @default.
• W2004991008 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24355089" @default.
• W2004991008 hasPublicationYear "2014" @default.
• W2004991008 type Work @default.
• W2004991008 sameAs 2004991008 @default.
• W2004991008 citedByCount "4" @default.
• W2004991008 countsByYear W20049910082016 @default.
• W2004991008 countsByYear W20049910082017 @default.
• W2004991008 countsByYear W20049910082021 @default.
• W2004991008 crossrefType "journal-article" @default.
• W2004991008 hasAuthorship W2004991008A5002438508 @default.
• W2004991008 hasAuthorship W2004991008A5009499168 @default.
• W2004991008 hasAuthorship W2004991008A5029936113 @default.
• W2004991008 hasAuthorship W2004991008A5052496992 @default.
• W2004991008 hasAuthorship W2004991008A5080964631 @default.
• W2004991008 hasAuthorship W2004991008A5084650313 @default.
• W2004991008 hasConcept C126322002 @default.
• W2004991008 hasConcept C144024400 @default.
• W2004991008 hasConcept C149923435 @default.
• W2004991008 hasConcept C159047783 @default.
• W2004991008 hasConcept C203014093 @default.
• W2004991008 hasConcept C22070199 @default.
• W2004991008 hasConcept C2780689484 @default.
• W2004991008 hasConcept C2780868878 @default.
• W2004991008 hasConcept C2908647359 @default.
• W2004991008 hasConcept C71924100 @default.
• W2004991008 hasConcept C72563966 @default.
• W2004991008 hasConcept C8891405 @default.
• W2004991008 hasConcept C99454951 @default.
• W2004991008 hasConceptScore W2004991008C126322002 @default.
• W2004991008 hasConceptScore W2004991008C144024400 @default.
• W2004991008 hasConceptScore W2004991008C149923435 @default.
• W2004991008 hasConceptScore W2004991008C159047783 @default.
• W2004991008 hasConceptScore W2004991008C203014093 @default.
• W2004991008 hasConceptScore W2004991008C22070199 @default.
• W2004991008 hasConceptScore W2004991008C2780689484 @default.
• W2004991008 hasConceptScore W2004991008C2780868878 @default.
• W2004991008 hasConceptScore W2004991008C2908647359 @default.
• W2004991008 hasConceptScore W2004991008C71924100 @default.
• W2004991008 hasConceptScore W2004991008C72563966 @default.
• W2004991008 hasConceptScore W2004991008C8891405 @default.
• W2004991008 hasConceptScore W2004991008C99454951 @default.
• W2004991008 hasIssue "6" @default.
• W2004991008 hasLocation W20049910081 @default.
• W2004991008 hasLocation W20049910082 @default.
• W2004991008 hasOpenAccess W2004991008 @default.
• W2004991008 hasPrimaryLocation W20049910081 @default.
• W2004991008 hasRelatedWork W2015260696 @default.
• W2004991008 hasRelatedWork W2019414446 @default.
• W2004991008 hasRelatedWork W2019574320 @default.
• W2004991008 hasRelatedWork W2029074520 @default.
• W2004991008 hasRelatedWork W2061876279 @default.
• W2004991008 hasRelatedWork W2397117160 @default.

• next